. 1994 Feb 2;271(5):341.

From the Centers for Disease Control and Prevention. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process

No authors listed

No authors listed. JAMA. 1994.

. 1994 Feb 2;271(5):341.

No abstract available

Similar articles

Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1994 Jan 14;43(1):17-8. MMWR Morb Mortal Wkly Rep. 1994. PMID: 8272047 No abstract available.
[Mycobacterium tuberculosis with extensive resistance].
Labie D. Labie D. Med Sci (Paris). 2007 Feb;23(2):205-9. doi: 10.1051/medsci/2007232205. Med Sci (Paris). 2007. PMID: 17291432 Review. French. No abstract available.
New generation methods for drug susceptibility testing for tuberculosis.
Katoch VM. Katoch VM. Indian J Tuberc. 2008 Apr;55(2):61-3. Indian J Tuberc. 2008. PMID: 18516820 No abstract available.
Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
Van Deun A, Wright A, Zignol M, Weyer K, Rieder HL. Van Deun A, et al. Int J Tuberc Lung Dis. 2011 Jan;15(1):116-24. Int J Tuberc Lung Dis. 2011. PMID: 21276307
[Multidrug-resistant tuberculosis].
Mori T. Mori T. Ryoikibetsu Shokogun Shirizu. 1999;(23 Pt 1):192-4. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10088371 Review. Japanese. No abstract available.

Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology.
Perovic O, Iyaloo S, Kularatne R, Lowman W, Bosman N, Wadula J, Seetharam S, Duse A, Mbelle N, Bamford C, Dawood H, Mahabeer Y, Bhola P, Abrahams S, Singh-Moodley A. Perovic O, et al. PLoS One. 2015 Dec 31;10(12):e0145429. doi: 10.1371/journal.pone.0145429. eCollection 2015. PLoS One. 2015. PMID: 26719975 Free PMC article.